Acneiform Eruption Due to Chemical clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
open to eligible people ages 18 years and up
The goal of this clinical trial is to learn about HT-001 Topical Gel for treatment of EGFR inhibitor-induced skin toxicities. The main questions it aims to answer are: - Determine the therapeutic effect of HT-001 for treatment of patients who…
at UC Irvine
Our lead scientists for Acneiform Eruption Due to Chemical research studies include Janellen Smith, MD.
Last updated: